C.J.GELATINE PRODUCTS LTD. (CJGEL) Fair Value & Analysis
Other · IN · Market cap ₹111M
Fair value as of: Aug 13, 2026
From 12 valuation models · updated 6 days ago
Below-average quality, and screening another 67% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹8.42). The favourable scenario is already priced in.
- Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹10.86 – ₹37.25 · fair‑value band ₹5.18 – ₹8.42 · the ₹19.90 price screens above the ₹6.47 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
C.J.GELATINE PRODUCTS LTD. (CJGEL) currently trades at ₹19.90, while our model-based Fair Value estimate is ₹6.47, implying the stock looks roughly 67.5% overvalued today. The Quality Score stands at 46/100 (below-average quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, C.J.GELATINE PRODUCTS LTD. generated revenue of ₹421M at a net margin of 0.5%. Revenue declined 0.2% year over year. It earns a return on equity of 5.2%. Net debt stands at ₹236M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹5.18 (bear case) to ₹8.42 (bull case); at ₹19.90, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 20% below its 52-week high and 43% above its 52-week low, currently above its 200-day average. For context, the median of 10 Other peers we cover trades at -24% fair-value upside, at -67%, CJGEL screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 12 models by family
Widest divergence: Multiples (₹7.36) versus Earnings-Based (₹2.45). Highest evidence: Growth-Adj P/E (68).
Notify me when CJGEL reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 41 · Market factors (momentum, volatility) 53
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
C.J. Gelatine Products Limited manufactures and sells gelatine and related by products in India. The company produces pharmaceutical, edible, technical, and photographic gelatins, as well as ossein and di-calcium phosphate. C.J. Gelatine Products Limited was founded in 1980 and is based in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
C.J.GELATINE PRODUCTS LTD. reported revenue of ₹421M in FY2026 versus ₹395M in FY2022, a compound +1.6%/yr. Reported net income was ₹2.1M in FY2026, compounding −12.0%/yr from FY2022.
CJGEL screens 67% overvalued. Compare with Federal Home Loan Mortgage Corporation →
Peer Group
Other · 381 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Other median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Federal Home Loan Mortgage Corporation FREJO | $15.58 | $51.90 | +233% |
| 533278 533278 | ₹409.15 | ₹660.78 | +62% |
| Nestl?? India Limited 500790 | ₹1,497 | ₹191.93 | -87% |
| ITC Limited 500875 | ₹279.50 | ₹212.74 | -24% |
| Wipro Limited 507685 | ₹183.80 | ₹193.38 | +5% |
| 540376 540376 | ₹4,054 | ₹1,542 | -62% |
| 540777 540777 | ₹537.50 | ₹149.72 | -72% |
| Lupin Limited 500257 | ₹2,265 | ₹1,983 | -12% |
| Dabur India Limited 500096 | ₹413.80 | ₹122.93 | -70% |
| 540719 540719 | ₹1,835 | ₹872.41 | -52% |
Compare C.J.GELATINE PRODUCTS LTD. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is C.J.GELATINE PRODUCTS LTD. (CJGEL) overvalued or undervalued?
What is the fair value of CJGEL?
What is the quality score of CJGEL?
What is the revenue of C.J.GELATINE PRODUCTS LTD. (CJGEL)?
What is the net profit margin of CJGEL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track C.J.GELATINE PRODUCTS LTD. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.